HopeStage
Back to overview

Bipolarity studies

Topics
More filters

Bipolarity

Bipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.

1979studies shown
Showing 1,369-1,380 of 1,979
Drug study icon
CompletedNCT03315897

Effects of Erythropoietin on Cognition and Neural Activity in Mood Disorders

Official study title

Effects of Erythropoietin on Cognitive Functions and Neural Activity in Cognitively Impaired Remitted Patients With Bipolar Disorder or Recurrent Depressive Disorder and Healthy People: Study Protocol for a Randomized, Controlled Trial

This study has finished and is no longer accepting participants.

In Copenhagen
Bipolarity, DepressionMedication studyAges 18–65
Countries
Denmark
Sponsor
Lars Vedel Kessing
Drug study icon
CompletedNCT00179062

Effects of Risperidone and Olanzapine on people with Schizophrenia, Schizoaffective Disorder, Major Depression or Bipolarity

Official study title

Effects of Risperidone and Olanzapine on Weight Gain, Physical Health, and Outcome in a Community Sample of Severity and Persistently Ill Patients

This study has finished and is no longer accepting participants.

In Nashville
Bipolarity, Depression, ...Medication studyAges 18–60
Countries
United States
Sponsor
Vanderbilt University
Drug study icon
CompletedNCT01303601

Efficacy of Olanzapine Monotherapy for Treatment Bipolar Ⅰ Depression

What is this study about?

Researchers compared olanzapine and placebo to find out how the approaches affected depression symptoms in people with depression.

This study has finished and is no longer accepting participants.

In Shenyang
Bipolarity, DepressionMedication studyAges 18–60
Countries
China
Sponsor
China Medical University, China
Other study type icon
CompletedNCT01998516

Emotional Intelligence in Schizophrenia and Bipolar-I- Disorder

Official study title

Emotional Intelligence in Schizophrenia and Bipolar I Disorder: a Comparison Between Patients, Their Siblings, and Healthy Controls

This study has finished and is no longer accepting participants.

In Innsbruck
Bipolarity, SchizophreniaObservational studyAges 18–65
Countries
Austria
Sponsor
Medical University Innsbruck
Behavioral study icon
CompletedNCT01361698

Illness Management and Recovery (IMR) in Danish Community Mental Health Centres

Official study title

Illness Management and Recovery (IMR) in Danish Community Mental Health Centres: Protocol of a Randomized, Assessor-blinded Multi-centre Clinical Trial of a Recovery-oriented Program for People With Schizophrenia or Bipolar Disorder

This study has finished and is no longer accepting participants.

In Ballerup and Frederiksberg
Schizophrenia, BipolarityBehavioural studyAges 18+
Countries
Denmark
Sponsor
Amager Hospital
Drug study icon
CompletedNCT00475137

Lamotrigine Alone Compared to Lamotrigine Plus Antidepressant for Bipolar II Depression

Official study title

A Randomized, Single-Blind Comparison of Lamotrigine Add-on Versus Switch to Lamotrigine Monotherapy in the Treatment of Bipolar II Depression Unresponsive to Antidepressant Treatment

This study has finished and is no longer accepting participants.

In Vancouver
Bipolarity, DepressionMedication studyAges 17–70
Countries
Canada
Sponsor
University of British Columbia
Drug study icon
CompletedNCT00868959

Lurasidone - A 24-week Extension Study of people with Bipolar I Depression

Official study title

A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression

This study has finished and is no longer accepting participants.

Multiple locations, including Little Rock
Bipolarity, DepressionMedication studyAges 18–75
Countries
United States, France, Canada, + 12 others
Sponsor
Sumitomo Pharma America, Inc.
Drug study icon
CompletedNCT00868452

Lurasidone - A 6-week Study of people with Bipolar I Depression (Add-on)

Official study title

A Randomized, 6-Week, Double-Blind, Placebo- Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression

This study has finished and is no longer accepting participants.

Multiple locations, including Little Rock
Bipolarity, DepressionMedication studyAges 18–75
Countries
United States, France, Czechia, + 7 others
Sponsor
Sumitomo Pharma America, Inc.
Drug study icon
CompletedNCT00868699

Lurasidone - A 6-week Study of people with Bipolar I Depression (Monotherapy)

What is this study about?

Researchers compared lurasidone and placebo to find out how the approaches affected depression symptoms in people with bipolarity type I during a depressive episode.

This study has finished and is no longer accepting participants.

Multiple locations, including Escondido
Bipolarity, DepressionMedication studyAges 18–75
Countries
United States, France, Czechia, + 5 others
Sponsor
Sumitomo Pharma America, Inc.

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.